4th Quarter - Report

CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R.486)

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 486 (113th)

Health Issues HCR

general health issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; issues relating to prescription drug abuse; Canada compliance issues

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.